Page 76 - GTM-4-2

Global Translational Medicine Glucosidase and metabolic profiles

Consent for publication 10. Douard V, Ferraris RP. Regulation of the fructose transporter
GLUT5 in health and disease. Am J Physiol Endocrinol
Not applicable. Metab. 2008;295:E227-E237.
Availability of data doi: 10.1152/ajpendo.90245.2008

Raw data can be obtained from the corresponding author 11. Leonhardt W, Hanefeld M, Fischer S, Schulze J. Efficacy
upon reasonable request. of alpha-glucosidase inhibitors on lipids in NIDDM
subjects with moderate hyperlipidemia. Eur J Clin Invest.
Further disclosure 1994;24 Suppl 3:45-49.
doi: 10.1111/j.1365-2362.1994.tb02256.x
An early shortened preliminary version of this paper was
released on Preprints and can be found at: doi: 10.20944/ 12. Monami M, Vitale V, Ambrosio ML, et al. Effects on lipid
preprints202411.1127.v1 profile of dipeptidyl peptidase 4 inhibitors, pioglitazone,
acarbose, and sulfonylureas: Meta-analysis of placebo-
References controlled trials. Adv Ther. 2012;29(9):736-746.
doi: 10.1007/s12325-012-0045-5
1. Kelly T, Yang CS, Reynolds K, He J. Global burden of
obesity in 2005 and projections to 2030. Int J Obes (Lond). 13. Leonhardt W, Hanefeld M, Fischer S, Schulze J, Spengler M.
2008;32(9):1431-1437. Beneficial effects on serum lipids in noninsulin dependent
diabetics by acarbose treatment. Arzneimittelforschung.
doi: 10.1038/ijo.2008.102
1991;41(7):735-738.
2. Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence 14. Hoffmann J, Spengler M. Efficacy of 24-week monotherapy
of cardiovascular-kidney-metabolic syndrome stages in US with acarbose, metformin, or placebo in dietary-
adults, 2011-2020. JAMA. 2024;331:1858-1860.
treated NIDDM patients: The Essen-II study. Am J Med.
doi: 10.1001/jama.2024.6892 1997;103(6):483-490.
3. Njoloma I, Lewis N, Sainvil F, et al. A primer on doi: 10.1016/s0002-9343(97)00252-0
hypertension and the racial/ethnic disparities in diagnosis 15. Chiasson JL, Naditch L, Miglitol Canadian University
and management. A comprehensive overview. Int J Family Investigator Group. The synergistic effect of miglitol plus
Clin Med. 2021;5(6):229-239. metformin combination therapy in the treatment of type 2
4. Available from: https://www.cdc.gov/diabetes/php/data- diabetes. Diabetes Care. 2001;24:989-994.
research/index.html; https://www.who.int/news-room/fact- doi: 10.2337/diacare.24.6.989
sheets/detail/diabetes [Last accessed on 2025 Mar 25].
16. Tulp OL. Biometry, adiposity and mechanism of protein
5. Soták M, Clark M, Suur BE, Börgeson E. Inflammation and sparing growth in congenic preobese LA/Ntul//-cp rats. Br
resolution in obesity. Nat Rev Endocrinol. 2025;21:45-61. J Healthc Med Res. 2023;10:364-374.
doi: 10.1038/s41574-024-01047-y doi: 10.14738/bjhmr.103.14969
6. Wiley CD, Campisi J. The metabolic roots of senescence: 17. Granner DK, Mayes PA, Murray RK, et al. Harpers Illustrated
mechanisms and opportunities for intervention. Nat Metab. Biochemistry. New York: McGraw-Hill Publications; 2012.
2021;3(10):1290-1301.
18. Tulp OL. Characteristics of thermogenesis, obesity, and
doi: 10.1038/s42255-021-00483-8 longevity in the LA/Ntul//–cp rat. ILAR J. 1990;32(3):32-39.

7. Malik A, Erginkaya Z, Erten H, editors. Health and Safety 19. Greenhouse DD. New Models of genetically obese rats for
Aspects of Food Processing Technologies. Ch. 1-23. Germany: studies of diabetes, heart disease, and complications of
Springer Publications; 2020. obesity. ILAR J. 1990;32(3):1-3.
doi: 10.1007/978-3-030-24903-8 20. Hansen CT. The development of the SHR/N and LA/N-cp
rat strains. In: NER Models of Genetically Obese Rats for
8. Bray GA. Energy and fructose from beverages sweetened
with sugar or high-fructose corn syrup pose a health risk for Studies in Diabetes, Heart Disease, and Complications of
some people. Adv Nutr. 2013;4:220-225. Obesity. Bethesda, MD, USA: NIH Publication, Division
of Research Services, Veterinary Resources Branch; 1988.
doi: 10.3945/an.112.002816 p. 7-10.
9. Assefa ST, Yang EY, Chae SY, et al. Alpha glucosidase 21. Jing AI, Wang N, Yang M, Du ZM, Zhang YC, Yang BF.
inhibitory activities of plants with focus on common Development of Wistar rat model of insulin resistance.
vegetables. Plants (Basel). 2020;9(1):2-19. World J Gastroenterol. 2005;11(24):3675-3679.
doi: 10.3390/plants9010002 doi: 10.3748/wjg.v11.i24.3675

Volume 4 Issue 2 (2025) 68 doi: 10.36922/gtm.6501